ohnson & Johnson Innovative Medicine company-sponsored congress materials which have been accepted for congress presentation at European Society for Medical Oncology

Translational Analyses of T-Cell Phenotypes and Their Association With Clinical Efficacy in the First-In-Human (FIH) Trial of JNJ-78278343 (Pasritamig) in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

CARVYKTI_US-SR-10459

CARVYKTI_US-SR-10545

Test-EL

Carvykti Dossier banner

Submit your medical inquiry

Contact J&J Medical Connect for your medical inquiries


This page was last modified on

Additional contact #{index}

janssenscience

Congress Materials

Payer

investigational-product

Dark Blue

oncology

translational-analyses-of-t-cell-phenotypes-video

Whitelist Modal

Translational Analyses of T-Cell Phenotypes and Their Association With Clinical Efficacy in the First-In-Human (FIH) Trial of JNJ-78278343 (Pasritamig) in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Connect with us

Connect with us

Live video

Waiting for agent...

Ready to join